Financhill
Back

Assembly Biosciences Quote, Financials, Valuation and Earnings

Assembly Biosciences Price Quote

$14.79
-0.23 (-1.53%)
(Updated: November 21, 2024 at 5:55 PM ET)

Assembly Biosciences Key Stats

Sell
36
Assembly Biosciences (ASMB) is a Sell

Day range:
$14.60 - $15.34
52-week range:
$7.69 - $19.93
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.19
P/B ratio:
3.87%

Volume:
19.2K
Avg. volume:
26.6K
1-year change:
86.54%
Market cap:
$100.7M
Revenue:
$7.2M
EPS:
$-6.92

How Much Does Assembly Biosciences Make?

Is Assembly Biosciences Growing As A Company?

Data Unavailable

Assembly Biosciences Stock Price Performance

What Is Assembly Biosciences 52-Week High & Low?

Assembly Biosciences Price To Free Cash Flow

Is It Risky To Buy Assembly Biosciences?

Is Assembly Biosciences Cash Flow Positive?

  • What Is ASMB Cash Flow From Operations?
    Cash flow from operations (TTM) is $22.9M
  • What Is Assembly Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $21.6M
  • What Is Assembly Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$42.8M

Assembly Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    ASMB return on invested capital is -115.86%
  • What Is Assembly Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -38.94%
  • What Is ASMB Return On Equity?
    ROE is a measure of profitability and is -115.86%

Assembly Biosciences Earnings Date & Stock Price

Assembly Biosciences Competitors

Assembly Biosciences Dividend Yield

Assembly Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 18.38%
Revenue: 0% -20.82%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 35.50
Upside from Last Price: 136.35%

Major Shareholders

  • How many ASMB shares are owned by institutional investors?
    14.7M ASMB shares are owned by institutional investors
  • How many ASMB shares are owned by insiders?
    2.4M ASMB shares are owned by insiders